Join the Race Oncology Board for an in-depth roundtable discussion on the company’s mission, scientific breakthroughs, and strategic roadmap. Hear from Dr Peter Smith, Dr Serge Scrofani, Dr Megan Baldwinand and Dr Daniel Tillett as they explore:

• How Race Oncology’s patient-focused mission drives decision-making

• Recent milestones, including IP advancements and mechanism of action insights

• The evolving oncology landscape and Race’s unique position

• Commercial opportunities, partnering strategies, and global ambitions

• Personal reflections from board members on resilience, governance, and innovation

This conversation offers a rare behind-the-scenes look at how Race Oncology is shaping the future of cancer treatment.

Watch here: https://youtu.be/nfM6VTBTwYQ